Quantitative analysis of bromocriptine mesylate in tablet formulations by HPLC

被引:6
作者
Foda, NH [1 ]
ElShafie, F [1 ]
机构
[1] KING SAUD UNIV,COLL PHARM,DEPT PHARMACEUT CHEM,RIYADH 11495,SAUDI ARABIA
关键词
D O I
10.1080/10826079608015818
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, specific and reliable high performance liquid chromatographic assay of bromocriptine mesylate in tablets has been developed. Reverse phase chromatography was conducted using a mobile phase of 0.05 M ammonium acetate and acetonitrile, (40% v/v) pH 5.6 and detection at 240 nm. The % recovery and coefficient of variation from six placebo tablets containing 2.5 mg of bromocriptine mesylate were 100.65 and 0.456 respectively. Replicate regression analyses of three standard plots in the concentration range 0.5 - 10 mcg/mL obtained on three different days gave a correlation coefficient >0.9997 and the coefficient of variation of the slopes <0.1%. The assay was precise within day and between days as indicated by ANOVA test. The percentage recoveries from 10 replicate tablets of two commercial brands was 99.4 and 102.8% of the label amount and their coefficients of variation were 1.51 and 1.07%.
引用
收藏
页码:3201 / 3209
页数:9
相关论文
共 5 条
[1]   LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY IN THE PHARMACEUTICAL-INDUSTRY - OBJECTIVES AND NEEDS [J].
ERNI, F .
JOURNAL OF CHROMATOGRAPHY, 1982, 251 (02) :141-151
[2]  
*HER MAJ STAT OFF, 1993, BRIT PHARM
[3]  
MARTINDALE, 1993, EXTRA PHARMACOPOEIA, P1275
[4]   EXPERIENCE WITH ROUTINE APPLICATIONS OF LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY IN THE PHARMACEUTICAL-INDUSTRY [J].
SCHELLENBERG, KH ;
LINDER, M ;
GROEPPELIN, A ;
ERNI, F .
JOURNAL OF CHROMATOGRAPHY, 1987, 394 (01) :239-251
[5]  
*US PHARM CONV INC, 1995, 18 USP NF, P219